http://www.nitrc.org/forum/forum.php?forum_id=5410 <table border="0" width="100%"><tr><td align="left"/><td align="right"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&amp;cmd=Link&amp;LinkName=pubmed_pubmed&amp;from_uid=26221294">Related Articles</a></td></tr></table> <p><b>The therapeutic effect of Xueshuan Xinmai tablets on memory injury and brain activity in post-stroke patients: a pilot placebo controlled fMRI study.</b></p> <p>Int J Clin Exp Med. 2015;8(5):7507-16</p> <p>Authors: Wei D, Lv C, Zhang J, Peng D, Hu L, Zhang Z, Wang Y</p> <p>Abstract<br/> OBJECTIVE: The purpose of this study was to explore the effects of Xueshuan Xinmai tablets (XXMT) for the treatment of cognition, brain activation in the rehabilitation period of ischemic stroke patients.<br/> METHODS: 28 adults patients, aged 50-80 years, in the rehabilitation period of ischemic stroke were divided into XXMT treatment group and placebo control group. Patients received 3 months treatment (oral 0.8 g, 3 times per day). Before and after treatment, all patients were evaluated by a series of neuropsychological tests followed by resting-state functional magnetic resonance imaging (fMRI).<br/> RESULTS: In the XXMT treatment group, the patients' episodic memory showed significant improvement. The resting-state fMRI analysis indicated that a significant decline in the fractional amplitude of low-frequency fluctuation value was observed in the bilateral middle cingulate gyrus.<br/> CONCLUSIONS: Yiqi Huoxue effect under XXMT administration has a favorable mediation on episodic memory, consequently suppresses the activation of the cingulate gyrus in the rehabilitation period of ischemic stroke patients.<br/> </p><p>PMID: 26221294 [PubMed]</p> en-us Copyright 2000-2026 NITRC OSI Sat, 02 May 2026 23:17:20 GMT http://blogs.law.harvard.edu/tech/rss NITRC RSS generator